Literature DB >> 14667815

Regulation of aldehyde reductase expression by STAF and CHOP.

Oleg A Barski1, Victor Z Papusha, Gary R Kunkel, Kenneth H Gabbay.   

Abstract

Aldehyde reductase is involved in the reductive detoxification of reactive aldehydes that can modify cellular macromolecules. To analyze the mechanism of basal regulation of aldehyde reductase expression, we cloned the murine gene and adjacent regulatory region and compared it to the human gene. The mouse enzyme exhibits substrate specificity similar to that of the human enzyme, but with a 2-fold higher catalytic efficiency. In contrast to the mouse gene, the human aldehyde reductase gene has two alternatively spliced transcripts. A fragment of 57 bp is sufficient for 25% of human promoter activity and consists of two elements. The 3' element binds transcription factors of the Sp1 family. Gel-shift assays and chromatin immunoprecipitation as well as deletion/mutation analysis reveal that selenocysteine tRNA transcription activating factor (STAF) binds to the 5' element and drives constitutive expression of both mouse and human aldehyde reductase. Aldehyde reductase thus becomes the fourth protein-encoding gene regulated by STAF. The human, but not the mouse, promoter also binds C/EBP homologous protein (CHOP), which competes with STAF for the same binding site. Transfection of the human promoter into ethoxyquin-treated mouse 3T3 cells induces a 3.5-fold increase in promoter activity and a CHOP-C/EBP band appears on gel shifts performed with the 5' probe from the human aldehyde reductase promoter. Induction is attenuated in similar transfection studies of the mouse promoter. Mutation of the CHOP-binding site in the human promoter abolishes CHOP binding and significantly reduces ethoxyquin induction, suggesting that CHOP mediates stimulated expression in response to antioxidants in the human. This subtle difference in the human promoter suggests a further evolution of the promoter toward responsiveness to exogenous stress and/or toxins.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14667815     DOI: 10.1016/s0888-7543(03)00213-1

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  14 in total

1.  Characterization of megakaryocyte GATA1-interacting proteins: the corepressor ETO2 and GATA1 interact to regulate terminal megakaryocyte maturation.

Authors:  Isla Hamlett; Julia Draper; John Strouboulis; Francisco Iborra; Catherine Porcher; Paresh Vyas
Journal:  Blood       Date:  2008-07-14       Impact factor: 22.113

Review 2.  The aldo-keto reductase superfamily and its role in drug metabolism and detoxification.

Authors:  Oleg A Barski; Srinivas M Tipparaju; Aruni Bhatnagar
Journal:  Drug Metab Rev       Date:  2008       Impact factor: 4.518

3.  Adhesion-dependent Skp2 transcription requires selenocysteine tRNA gene transcription-activating factor (STAF).

Authors:  Ivette Hernández-Negrete; Graciela B Sala-Newby; Andras Perl; Gary R Kunkel; Andrew C Newby; Mark Bond
Journal:  Biochem J       Date:  2011-05-15       Impact factor: 3.857

4.  Substrate specificity and catalytic efficiency of aldo-keto reductases with phospholipid aldehydes.

Authors:  Matthew Spite; Shahid P Baba; Yonis Ahmed; Oleg A Barski; Kanchan Nijhawan; J Mark Petrash; Aruni Bhatnagar; Sanjay Srivastava
Journal:  Biochem J       Date:  2007-07-01       Impact factor: 3.857

5.  Catalytic mechanism and substrate specificity of the beta-subunit of the voltage-gated potassium channel.

Authors:  Srinivas M Tipparaju; Oleg A Barski; Sanjay Srivastava; Aruni Bhatnagar
Journal:  Biochemistry       Date:  2008-08-02       Impact factor: 3.162

6.  Validation of differential GDAP1 DNA methylation in alcohol dependence and its potential function as a biomarker for disease severity and therapy outcome.

Authors:  Christof Brückmann; Adriana Di Santo; Kathrin Nora Karle; Anil Batra; Vanessa Nieratschker
Journal:  Epigenetics       Date:  2016-04-29       Impact factor: 4.528

7.  The selenocysteine tRNA STAF-binding region is essential for adequate selenocysteine tRNA status, selenoprotein expression and early age survival of mice.

Authors:  Bradley A Carlson; Ulrich Schweizer; Christine Perella; Rajeev K Shrimali; Lionel Feigenbaum; Liya Shen; Svetlana Speransky; Thomas Floss; Soon-Jeong Jeong; Jennifer Watts; Victoria Hoffmann; Gerald F Combs; Vadim N Gladyshev; Dolph L Hatfield
Journal:  Biochem J       Date:  2009-02-15       Impact factor: 3.857

8.  The transcriptional activator ZNF143 is essential for normal development in zebrafish.

Authors:  Kari M Halbig; Arne C Lekven; Gary R Kunkel
Journal:  BMC Mol Biol       Date:  2012-01-23       Impact factor: 2.946

9.  Regulation of aldo-keto reductases in human diseases.

Authors:  Wei-Dong Chen; Yanqiao Zhang
Journal:  Front Pharmacol       Date:  2012-03-09       Impact factor: 5.810

Review 10.  Mouse models targeting selenocysteine tRNA expression for elucidating the role of selenoproteins in health and development.

Authors:  Bradley A Carlson; Min-Hyuk Yoo; Petra A Tsuji; Vadim N Gladyshev; Dolph L Hatfield
Journal:  Molecules       Date:  2009-09-10       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.